| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS612194 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS601817 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS601815 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS627086 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS618712 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS632884 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS632886 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS632885 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIES | CS633507 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CS705928 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CS707065 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CS707066 | 5x5um | ORIGENE TECHNOLOGIES |
| Sparcl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516537 | 1 kit | ORIGENE TECHNOLOGIES |
| SPARCL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH326078 | 10 ug | ORIGENE TECHNOLOGIES |
| SPARCL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407583 | 1 kit | ORIGENE TECHNOLOGIES |
| SPARCL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307583 | 10 ug | ORIGENE TECHNOLOGIES |
| SPARC Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309964 | 10 ug | ORIGENE TECHNOLOGIES |
| Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 (SPOCK3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421701 | 100 ug | ORIGENE TECHNOLOGIES |
| Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 (SPOCK2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY414995 | 100 ug | ORIGENE TECHNOLOGIES |
| SPARC related modular calcium binding 2 (SMOC2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402910 | 100 ug | ORIGENE TECHNOLOGIES |
| SPARC related modular calcium binding 1 (SMOC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400412 | 100 ug | ORIGENE TECHNOLOGIES |
| SPARC related modular calcium binding 1 (SMOC1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY411742 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426876 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426877 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413881 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIES | LY401085 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402406 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428019 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428018 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastin (SPAST), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404560 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4 from ORIGENE TECHNOLOGIES | LY428017 | 100 ug | ORIGENE TECHNOLOGIES |
| Spast - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516538 | 1 kit | ORIGENE TECHNOLOGIES |
| SPAST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH320458 | 10 ug | ORIGENE TECHNOLOGIES |
| SPAST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH314100 | 10 ug | ORIGENE TECHNOLOGIES |
| SPAST - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414100 | 1 kit | ORIGENE TECHNOLOGIES |
| SPATA31A7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406917 | 1 kit | ORIGENE TECHNOLOGIES |
| SPATA31A1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413700 | 1 kit | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 41 (TRIM41), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409431 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 54 (TRIM54), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403171 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 45 (TRIM45), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410850 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 54 (TRIM54), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405178 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 55 (TRIM55), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405209 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 55 (TRIM55), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430670 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 7 (TRIM7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404377 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 6 (TRIM6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403302 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 7 (TRIM7), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404379 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 7 (TRIM7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404381 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 9 (TRIM9), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409342 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 9 (TRIM9), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429452 | 100 ug | ORIGENE TECHNOLOGIES |
| Tripartite motif-containing 33 (TRIM33), transcript variant a from ORIGENE TECHNOLOGIES | LY414337 | 100 ug | ORIGENE TECHNOLOGIES |